A new study published in The American Journal of Pathology reveals that gastrointestinal side effects caused by morphine can be reversed through treatment with proton pump inhibitor drugs like omeprazole. Morphine remains a gold standard for pain management, but its use frequently results in significant complications, including nausea, vomiting, and constipation.
How Morphine Triggers Gastric Damage
According to lead investigator Sabita Roy, PhD, from the Department of Surgery at the Miller School of Medicine and the Sylvester Comprehensive Cancer Center at the University of Miami, researchers have spent considerable time deciphering the mechanisms behind these adverse effects. To investigate the phenomenon, researchers treated mice with morphine or a placebo. In vivo imaging confirmed that the morphine-treated mice experienced delayed gastric emptying, which led to an accumulation of acid and increased retention time in the stomach.
The resulting gastric damage included significant disruption of gastric mucosal cells, a reduced glandular region, and increased gastric cell death. Dr. Roy and co-investigators observed that classic opiate receptors are involved in the process, noting that these receptors exist in high concentrations in the gastric antrum near the small intestine. When researchers administered naloxone—a synthetic drug that blocks opioid receptor function—these damaging effects were reduced in the morphine-treated mice.
The Role of the Cytokine IL-6 in Gastric Inflammation
The study identified the cytokine IL-6 as a key driver in the regulation of opioid-induced delays in gastric emptying and subsequent tissue damage. Morphine-treated mice exhibited elevated levels of IL-6. To confirm this pathway, researchers tested mice that lacked IL-6. When these mice received morphine, delays in gastric emptying decreased, no gastric inflammation was detected, and pH levels remained comparable to the placebo group. This demonstrated that an acute increase in IL-6 following morphine treatment causes the gastric emptying delay that leads to acid accumulation and inflammation.
Omeprazole Offers Gastroprotection Without Compromising Pain Relief
A central finding of the research is that co-administering the over-the-counter proton pump inhibitor omeprazole with morphine provides effective gastroprotection. Omeprazole blocks gastric acid secretion, directly reducing gastric delay and inflammation while improving morphine tolerance. Investigators also addressed whether omeprazole compromises the analgesic efficacy of morphine. Pretreatment with omeprazole resulted in a significant improvement in morphine-induced analgesic tolerance, which researchers attribute to the drug’s ability to break the cycle of chronic tolerance by reducing proinflammatory cytokines.
“Our studies have clear clinical implications and suggest that omeprazole treatment at the time of morphine administration is a promising, safe, and inexpensive approach for reducing morphine-induced gastrointestinal pathology, improving morphine analgesic tolerance, and prolonging its efficacy as an analgesic agent,” Dr. Roy stated in the report.